NCT04447820View on ClinicalTrials.gov

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

December 3, 2020

Study Completion Date

December 3, 2020

Conditions
Dyslipidemia
Interventions
DRUG

K-877-ER (Dose A)

Dose A Oral Administration

DRUG

K-877-ER (Dose B)

Dose B Oral Administration

DRUG

K-877-IR

K-877-IR Oral Administration

Trial Locations (12)

20110

Manassas Clinical Research Center, Manassas

28557

Diabetes and Endocrinology Consultants, P.C., Morehead City

31904

Columbus Regional Health, Columbus

32127

Progressive Medical Research, Port Orange

32216

Jacksonville Center for Clinical Research, Jacksonville

36207

Pinnacle Research Group, Anniston

43213

Aventiv Research, Inc., Columbus

44262

Summit Research Group, LLC, Munroe Falls

45227

Medpace Clinical Pharmacology, LLC, Cincinnati

55114

Prism Research, Saint Paul

57702

Health Concepts, Rapid City

78229

Clinical Trials of Texas, Inc., San Antonio

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY